Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort
Journal of Clinical Medicine · 07.04.2026 · 15 (7) · 2778
DOI: 10.3390/jcm15072778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.04.2026. Verfasst von Carlos Rabaça und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Treatment of Urological Diseases, R. Dom Manuel I n° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Prostate cancer is one of the most common malignancies diagnosed in men worldwide. Brachytherapy (BT), particularly low-dose rate (LDR)-BT, has been shown to be a successful treatment. The aim of this study was to evaluate the effectiveness of BT treatment in localized prostate cancer patients from a single-center Portuguese cohort.
Methods
This was a retrospective study that evaluated prostate cancer patients followed up at the Center for the Treatment of Urological Diseases, Coimbra, Portugal, who underwent LDR-BT between November 2007 and March 2024. Overall survival (OS), biochemical recurrence-free survival (BRFS) and complications post-LDR BT treatment were evaluated during patients’ follow-up time.
Results
A total of 1343 patients treated with LDR-BT were recruited. Global OS and BRFS rates were 98.4% and 87.7%, respectively. A reduced frequency of complications such as lower urinary tract symptoms, erectile dysfunction, acute urinary retention, radiation proctitis and stress urinary incontinence were described. High OS (>98%) and BRFS rates were observed particularly in low and intermediate disease risk. Prostate-specific antigen (PSA) serum levels > 20 ng/mL, Gleason score (GS) ≥ 8 and clinical tumor stage (cT) ≥ T2c were identified as the strongest predictors of death and/or biochemical recurrence.
Conclusions
BT is an effective treatment in localized prostate cancer patients, with comparable outcomes and consistent with the OS and BRFS rates reported in the current literature for radical prostatectomy and external beam radiotherapy approaches, and with a reduced frequency of complications. PSA serum levels > 20 ng/mL, GS ≥ 8 and cT stage ≥ T2c can be used as strong predictors of death and/or biochemical recurrence during patients’ follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for the Treatment of Urological Diseases, R. Dom Manuel I n° 8, Estádio Cidade de Coimbra, 3030-320 Coimbra, Portugal.
- Portuguese Institute of Oncology of Coimbra, Av. Bissaya Barreto 98, 3000-075 Coimbra, Portugal.
- Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, Celas, 3000-548 Coimbra, Portugal.
- Joaquim Chaves Saúde, Rua Aníbal Bettencourt, n° 3, Edifício CORE, 2790-225 Carnaxide, Portugal.
- Faculty of Health Sciences, University Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
- Hospital Lusíadas, Av. dos Hospitais Civis de Lisboa 8, 2724-002 Amadora, Portugal.
ORCID-Profile: Carlos Rabaça, Domingos Roda, Bruno Pereira, José Alberto Pereira
Zitieren
APA
Rabaça, C., Roda, D., Vieira, G., Pereira, B., Godinho, R., Lourenço, M., Pereira, J. A., Regencio, M., Macedo, S., & Sismeiro, A. (2026). Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort. Journal of Clinical Medicine, 15(7), 2778. https://doi.org/10.3390/jcm15072778
Vancouver
Rabaça C, Roda D, Vieira G, Pereira B, Godinho R, Lourenço M, et al. Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort. Journal of Clinical Medicine. 2026;15(7):2778. doi:10.3390/jcm15072778
BibTeX
@article{Rabaa2026,
author = {Rabaça, Carlos and Roda, Domingos and Vieira, Guy and Pereira, Bruno and Godinho, Ricardo and Lourenço, Mário and Pereira, José Alberto and Regencio, Margarida and Macedo, Sofia and Sismeiro, Amilcar},
title = {Long-Term Outcomes of Low-Dose-Rate Brachytherapy in Localized Prostate Cancer: A 17-Year Retrospective Analysis of a Single-Center Portuguese Cohort},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2778},
doi = {10.3390/jcm15072778}
}
EUVIMED